1. Home
  2. MNOV vs KNDI Comparison

MNOV vs KNDI Comparison

Compare MNOV & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • KNDI
  • Stock Information
  • Founded
  • MNOV 2000
  • KNDI 2002
  • Country
  • MNOV United States
  • KNDI China
  • Employees
  • MNOV N/A
  • KNDI N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • MNOV Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • MNOV Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • MNOV 68.2M
  • KNDI 96.3M
  • IPO Year
  • MNOV 2005
  • KNDI N/A
  • Fundamental
  • Price
  • MNOV $1.27
  • KNDI $1.09
  • Analyst Decision
  • MNOV Strong Buy
  • KNDI
  • Analyst Count
  • MNOV 2
  • KNDI 0
  • Target Price
  • MNOV $7.00
  • KNDI N/A
  • AVG Volume (30 Days)
  • MNOV 13.0K
  • KNDI 94.0K
  • Earning Date
  • MNOV 08-07-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • MNOV N/A
  • KNDI N/A
  • EPS Growth
  • MNOV N/A
  • KNDI N/A
  • EPS
  • MNOV N/A
  • KNDI N/A
  • Revenue
  • MNOV N/A
  • KNDI $127,569,613.00
  • Revenue This Year
  • MNOV N/A
  • KNDI N/A
  • Revenue Next Year
  • MNOV N/A
  • KNDI N/A
  • P/E Ratio
  • MNOV N/A
  • KNDI N/A
  • Revenue Growth
  • MNOV N/A
  • KNDI 3.21
  • 52 Week Low
  • MNOV $1.12
  • KNDI $0.89
  • 52 Week High
  • MNOV $2.55
  • KNDI $2.24
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 38.98
  • KNDI 45.17
  • Support Level
  • MNOV $1.32
  • KNDI $1.06
  • Resistance Level
  • MNOV $1.38
  • KNDI $1.16
  • Average True Range (ATR)
  • MNOV 0.05
  • KNDI 0.07
  • MACD
  • MNOV -0.00
  • KNDI 0.00
  • Stochastic Oscillator
  • MNOV 14.29
  • KNDI 26.67

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: